Shanghai Haohai Biological Tech Co (688366) — Cash Flow-to-Debt Ratio
Shanghai Haohai Biological Tech Co (688366) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥109.13 Million could theoretically repay 0% of its total liabilities (CN¥1.23 Billion) in one year. See 688366 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Haohai Biological Tech Co Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Shanghai Haohai Biological Tech Co across 13 annual periods. Also explore 688366 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Haohai Biological Tech Co (2012–2024)
Year-by-year debt coverage analysis for Shanghai Haohai Biological Tech Co. For market capitalisation and broader financial context, see market value of Shanghai Haohai Biological Tech Co.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥648.57 Million | CN¥1.20 Billion | ▼ -7.6% |
| 2023 | 0.58x | CN¥634.45 Million | CN¥1.09 Billion | ▲ +149.6% |
| 2022 | 0.23x | CN¥231.30 Million | CN¥990.02 Million | ▼ -39.2% |
| 2021 | 0.38x | CN¥342.29 Million | CN¥890.07 Million | ▼ -17.2% |
| 2020 | 0.46x | CN¥262.07 Million | CN¥564.46 Million | ▼ -33.7% |
| 2019 | 0.70x | CN¥348.91 Million | CN¥498.52 Million | ▲ +7.5% |
| 2018 | 0.65x | CN¥391.28 Million | CN¥600.90 Million | ▲ +34.5% |
| 2017 | 0.48x | CN¥343.06 Million | CN¥708.59 Million | ▲ +34.6% |
| 2016 | 0.36x | CN¥254.49 Million | CN¥707.55 Million | ▼ -79.0% |
| 2015 | 1.72x | CN¥268.51 Million | CN¥156.48 Million | ▲ +90.6% |
| 2014 | 0.90x | CN¥141.99 Million | CN¥157.74 Million | ▼ -53.4% |
| 2013 | 1.93x | CN¥146.91 Million | CN¥76.13 Million | ▼ -10.9% |
| 2012 | 2.16x | CN¥118.42 Million | CN¥54.70 Million | — |